(2-甲氧基-5-甲基苯基)乙腈 | 7048-42-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (2-甲氧基-5-甲基苯基)乙腈
• 英文名称: (2-methoxy-5-methylphenyl)-acetonitrile
• 英文别名: 1-(cyanomethyl)-2-methoxy-5-methylbenzene；2-methoxy-5-methylbenzeneacetonitrile；5-Methyl-2-methoxy-benzylcyanid；(6-Methoxy-3-methyl-phenyl)-essigsaeure-nitril；(2-Methoxy-5-methylphenyl)acetonitrile；2-(2-methoxy-5-methylphenyl)acetonitrile
• CAS: 7048-42-2
• 化学式: C₁₀H₁₁NO
• mdl: MFCD07310147
• 分子量: 161.203
• InChiKey: PNSVXFHBPNXSFB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  (2-甲氧基-5-甲基苯基)乙腈 在 ammonium hydroxide 、 镍 作用下， 以 乙醇 为溶剂， 反应 48.0h， 生成 2-(2-甲氧基-5-甲基苯基)乙胺
  参考文献：
  名称：

  Design and Synthesis of New Naphthalenic Derivatives as Ligands for 2-[125I]Iodomelatonin Binding Sites

  摘要：

  New melatonin-like agents were designed from the frameworks of 2,5-dimethoxyphenethylamine, an important structural moiety for the 5-HT receptor, and (2-methoxynaphthyl)-ethylamine. The compounds were synthesized by classical methods and evaluated in binding assays with chicken brain membranes using 2-[I-125]iodomelatonin as the radioligand. Preliminary studies on the series of N-acyl-disubstituted phenethylamines showed the favorable role of the methoxy group in the ortho position of the side chain on the affinity for the receptor K-i = 8 +/- 0.2 nM) for N-[2-(2-methoxy-5-bromophenyl)ethyl]propionamide (3o). This effect was confirmed in a series of the naphthalene derivatives, a bioisosteric moiety of the indole ring, and several potent ligands for melatonin binding sites were prepared such as N-[2-(2-methoxynaphthyl)ethyl]propionamide (4b) (K-i = 0.67 +/- 0.05 nM) and N-[2-(2,7-dimethoxynaphthyl)ethyl]cyclopropylformamide (K-i = 0.05 +/- 0.004 nM) (4k). Structure-activity relationships are discussed with regard to melatonin and bioisosteric naphthalenic compound 2. The K-i value for 4b was affected to a similar extent to that of melatonin by GTP-gamma-S or Mn2+ in competition experiments, suggesting an agonist profile for this compound.

  DOI：

  10.1021/jm00012a004
• 作为产物：
  描述：

  (2-methoxy-5-methylphenyl)methanol 在 四丁基氟化铵 、 三溴化磷 作用下， 以 四氢呋喃 、 二氯甲烷 、 乙腈 为溶剂， 反应 6.0h， 生成 (2-甲氧基-5-甲基苯基)乙腈
  参考文献：
  名称：

  [EN] SMALL MOLECULE CORRECTORS OF MAMMALIAN SLC6A8 FUNCTION
  [FR] CORRECTEURS À PETITES MOLÉCULES DE LA FONCTION SLC6A8 DE MAMMIFÈRE

  摘要：

  本发明涉及用于治疗或预防与蛋白质突变相关的疾病或障碍的化合物、组合物和方法。

  公开号：

  WO2022020247A1

文献信息

• [EN] 3,9-DIAZASPIRO[5.5]UNDECANE COMPOUNDS<br/>[FR] COMPOSÉS DE 3,9-DIAZASPIRO[5.5]UNDÉCANE
  申请人：BAYER AG

  公开号：WO2020048829A1

  公开（公告）日：2020-03-12

  The present invention covers 3,9-diazaspiro[5.5]undecane compounds of general formula (I) and general formula (I-a), in which R1, R2, R3 and R4 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

  本发明涵盖了一般式(I)和一般式(I-a)的3,9-二氮杂螺[5.5]十一烷化合物，其中R1、R2、R3和R4如本文所定义，制备所述化合物的方法，用于制备所述化合物的中间化合物，包含所述化合物的药物组合物和组合物，以及利用所述化合物制造用于治疗和/或预防疾病的药物组合物，特别是治疗过度增殖性疾病，作为唯一药剂或与其他活性成分组合使用。
• 8-Substituted isoquinoline derivative and the use thereof
  申请人：Kaneko Shunsuke

  公开号：US20100261701A1

  公开（公告）日：2010-10-14

  The present invention relates to a compound represented by the following formula (1): wherein D 1 , A 1 , D 2 , R 1 , D 3 , and R 2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

  本发明涉及一种由以下式（1）表示的化合物： 其中D1，A1，D2，R1，D3和R2分别具有与本说明书中定义的相同含义或其盐。由式（1）表示的化合物或其盐具有IKKβ抑制活性等，对于预防和/或治疗IKKβ相关疾病或症状等方面是有用的。
• 8-Oxoadenine Compound
  申请人：Ogita Haruhisa

  公开号：US20070225303A1

  公开（公告）日：2007-09-27

  An 8-oxoadenine compound useful as an immuno-modulator having specific activity against Th1/Th2, specifically a prophylactic and therapeutic agent for a topical application for allergic diseases, viral diseases and cancers, which is represented by the following formula (1): wherein A is a group of a formula represented by the formula (2): wherein R 2 is a substituted or unsubstituted alkyl group and so on, R 3 is hydrogen atom or an alkyl group, R is a halogen atom and so on, n is 0˜2, X 1 is oxygen atom, Z is straight or branched chain alkylene, and R 1 is an alkyl group which is optionally substituted by hydroxy group, an alkoxy group, alkoxycarbonyl group and so on, or its pharmaceutically acceptable salt.

  一种8-氧腺嘌呤化合物，可用作免疫调节剂，对Th1 / Th2具有特定活性，特别是用于过敏性疾病，病毒性疾病和癌症的局部应用的预防和治疗剂，其化学式（1）如下：其中A是由式（2）表示的式的基团：其中R2是取代或未取代的烷基基团等，R3是氢原子或烷基基团，R是卤素原子等，n为0〜2，X1为氧原子，Z为直链或支链烷基，R1为烷基基团，可选地由羟基基团，烷氧基基团，烷氧羰基基团等取代，或其药学上可接受的盐。
• 8-OXOADENINE COMPOUND
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP1728792A1

  公开（公告）日：2006-12-06

  An 8-oxoadenine compound useful as an immuno-modulator having specific activity against Th1/Th2, specifically a prophylactic and therapeutic agent for a topical application for allergic diseases, viral siseases and cancers, which is represented by the following formula (1): , wherein A is a group of a formula represented by the formula (2): , wherein R2 is a substituted or unsubstituted alkyl group and so on, R3 is hydrogen atom or an alkyl group, R is a halogen atom and so on, n is 0-2, X1 is oxygen atom, Z is straight or branched chain alkylene, and R1 is an alkyl group which is optionally substituted by hydroxy group, an alkoxy group, alkoxycarbonyl group and so on, or its pharmaceutically acceptable salt.

  一种 8-氧代腺嘌呤化合物，可用作对 Th1/Th2 具有特异性活性的免疫调节剂，特别是用于过敏性疾病、病毒性疾病和癌症的局部预防和治疗剂，由下式（1）表示： 其中 A 是由式（2）表示的一个式组： 其中 R2 是取代或未取代的烷基等，R3 是氢原子或烷基，R 是卤素原子等、 n 为 0-2、 X1 是氧原子，Z 是直链或支链亚烷基，R1 是可选被羟基、烷氧基、烷氧羰基等取代的烷基、 或其药学上可接受的盐。
• 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF
  申请人：Asahi Kasei Pharma Corporation

  公开号：EP2366699A1

  公开（公告）日：2011-09-21

  The present invention relates to a compound represented by the following formula (1): wherein D1, A1, D2, R1, D3, and R2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

  本发明涉及下式（1）所代表的化合物： 其中 D1、A1、D2、R1、D3 和 R2 各具有与本说明书中定义相同的含义或其盐。式（1）代表的化合物或其盐具有 IKKβ 抑制活性等，可用于预防和/或治疗 IKKβ 相关疾病或症状等。